Results 71 to 80 of about 25,643 (173)
Treatment strategies for interstitial granulomatous dermatitis: Systematic review and expert opinion
Journal of the European Academy of Dermatology and Venereology, EarlyView.Systematic review of 108 studies with a total of 182 patients with interstitial granulomatous dermatitis (IGD). IGD was frequently associated with systemic conditions or drug exposure. Management includes careful medication review and prompt withdrawal of potential triggers. Corticosteroids (systemic and topical) were commonly effective, while biologic
Francesco Bellinato +4 more
wiley +1 more source
Physiologically based pharmacokinetic (PBPK) model of enalapril
<p>This repository provides the enalapril physiologically based pharmacokinetic (PBPK) model.</p> <p>If you have any questions or problems please <a href="https://github.com/matthiaskoenig/enalapril-model/issues">open an issue</
König, Matthias, Palwankar, Shubhankar
core +1 more source
Patient Preference and Adherence, 2013 Borghi C, Santi F.Patient Preference and Adherence. 2012;6:449–455. On page 452, Table 1: Effect of fixed association of enalapril–lercanidipine on blood pressure control.
Borghi C, Santi F
doaj
The Journal of Physiology, EarlyView.Abstract figure legend ACE I/D genotype, enzyme activity and integrated physiological adaptations. Upper panel: Conceptual framework linking the ACE I/D polymorphism (left) with circulating/tissue ACE activity (centre; violin plots based on hypothetical data for illustration) and strength/power versus endurance phenotypes (right).
Tórur Sjúrðarson +1 more
wiley +1 more source
American Journal of Medical Genetics Part A, Volume 200, Issue 9, Page 2140-2150, September 2026.ABSTRACT Multiple Acyl‐CoA Dehydrogenase Deficiency (MADD) is an autosomal recessive inborn error of metabolism caused by biallelic pathogenic variants in one of three known genes: ETFA, ETFB, and ETFDH. It can cause multisystem dysfunction, including cardiomyopathy in severe cases.
Yutaka Furuta +17 more
wiley +1 more source
Enalapril reduces proliferation and hyaluronic acid release in orbital fibroblasts [PDF]
, 2013 BACKGROUND: Orbital fibroblast proliferation and hyaluronic acid (HA) release are responsible for some of the clinical features of Graves' ophthalmopathy (GO). Thus, inhibition of these processes may be a possible therapeutic approach to this syndrome.
MARINO', MICHELE +17 more
core +1 more source
British Journal of Clinical Pharmacology, Volume 92, Issue 9, Page 3246-3256, September 2026.Aim We aimed to investigate whether genetic variation is associated with venous thromboembolism after immunization with SARS‐CoV‐2 vaccines. Methods We conducted a genome‐wide association study (GWAS) on cases of venous thromboembolism within 42 days after SARS‐CoV‐2 vaccination, recruited from reports of adverse drug reactions sent to the Swedish ...
Sofia Attelind +7 more
wiley +1 more source
Agranulocytosis Associated with Enalapril
, 1991 An 83-year-old patient developed agranulocytosis following six months of enalapril 10 mg/d. The patient also had received verapamil for three years. Upon discontinuation of both drugs the white blood cell count was rapidly restored.
Ruth Lang +3 more
core +1 more source
Arquivo Brasileiro de Medicina Veterinária e Zootecnia, 2016 The aim of this study was to verify whether enalapril and captopril would reverse the renal damage caused by N-methylglucamine antimoniate in C57BL/6 mice. We used inbred C57BL/6 female mice, obtained from the Oswaldo Cruz Foundation (FIOCRUZ), Salvador,
S.S. Oliveira +3 more
doaj +1 more source
Enalapril therapy and thrombotic and inflammatory abnormalities in essential arterial hypertension
Кардиоваскулярная терапия и профилактика, 2005 Aim. During enalapril therapy in essential arterial hypertension (EAH) patients, to assess correction of the factors determining arterial thrombosis and inflammatory changes in arterial wall. Material and methods.
O. M. Moiseeva +3 more
doaj